The present invention relates to new dibenzothiazepine modulators of D1 receptors, D2 receptors, alpha-1 adrenergic receptors, alpha-2 adrenergic receptors, H1 receptors, 5-HT1A receptors, and/or 5-HT2 receptors, pharmaceutical compositions thereof, and methods of use thereof.
本发明涉及新的
二苯并噻吩D1受体、D2受体、α-1
肾上腺素受体、α-2
肾上腺素受体、H1受体、5-HT1A受体和/或5-HT2受体调节剂,其药物组合物以及其使用方法。